This inventor holds 3 USPTO granted patents. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: The Innovative Contributions of Bruno Roux
Introduction
Bruno Roux is a notable inventor based in Lyon, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address cardiovascular diseases and other medical conditions. With a total of 3 patents to his name, Roux's work exemplifies the intersection of innovation and healthcare.
Latest Patents
Roux's latest patents include groundbreaking inventions such as "Trifluoromethylbenzamide derivatives and therapeutic uses thereof." This patent focuses on compounds that are useful in treating cardiovascular diseases, detailing processes for their preparation and pharmaceutical compositions that incorporate them. Another significant patent is for "Azaindole inhibitors of MTP and ApoB," which relates to 7-azaindole-based compounds. This invention outlines processes for their preparation and their use in creating medicaments that inhibit MTP and ApoB secretion.
Career Highlights
Throughout his career, Roux has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft. His experience in these organizations has allowed him to refine his expertise in patent development and pharmaceutical innovation.
Collaborations
Roux has collaborated with several professionals in his field, including Isabelle Berard and Olivier Chevreuil. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Bruno Roux's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the medical community, particularly in the treatment of cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
